Cannabis Business Alliance (CBA) Lauds Colorado General Assembly for a Successful 2017 Legislative Session

CBA Five years SAM Cannabis Business Alliance CBA

DENVER, May 12, 2017 /Weed Wire/ — As the 2017 General Assembly Session comes to a close, the Cannabis Business Alliance (CBA) applauds legislators for another productive session in regards to the continued regulation of the legal cannabis industry in Colorado.

“CBA commends the work of our elected officials for continuing a sensible approach to the further regulation of an already overly regulated cannabis industry,” noted Peggy Moore, Board President, CBA. “As the cannabis industry continues to flourish in Colorado, it is critical that the state has the opportunity to research and measure the effectiveness of current regulations. The work conducted this session will continue to enable the success of a fledgling industry that supports state coffers while diverting power from the black market and organized crime.”

Highlights from the session include:

Medical Marijuana License Issues (HB17‐1034): Concerning licensing changes to the medical marijuana code to align with the retail marijuana code. CBA successfully amended the bill to allow medical MIP to MIP transfers. Signed by the Governor.

Gray and Black Market Marijuana Enforcement Efforts (HB17‐1221): Creates the grey/black market marijuana enforcement grant program in the division of local government in the department of local affairs, which will award grants to local governments to reimburse for training, education, law enforcement & prosecution costs associated with grey/ black marijuana markets. Sent to the Governor on 5/2/17.

Prevent Marijuana Diversion to Illegal Market (HB17‐1220): Aims to stop diversion of legal marijuana to the illegal market by limiting the number of plants that can be possessed or grown on a residential property to 12 plants, with 6 or fewer being mature. Sent to the Governor on 5/2/17.

Authorize Marijuana Clinical Research (HB17‐1367): Allows for research and development of marijuana in Colorado by creating a marijuana research and development license for research purposes. Under the bill, a marijuana research and development licensee may contract with a public research institution of higher education or another marijuana research and development licensee. SB 275 was amended into the bill on the Senate floor. Passed both Houses, sent to the Governor.

Unlawful Marijuana Advertising Bill (SB17‐015): Makes advertising of an unlicensed marijuana product (ie, Craig’s List) a level 2 drug misdemeanor. Signed by the Governor on 4/4/17.

Allow Medical MJ Use For Stress Disorders Bill (SB17-017): Adds acute stress disorder and PTSD to the list of debilitating medical conditions for the purposes of the use of medical marijuana. Awaiting the Governor’s signature.

Medical Marijuana Inventory Shortfall Fixes (SB17‐111): The bill allows the department to determine the percentage, but limits them from going below 30 percent. A medical marijuana center may transfer medical marijuana to another medical marijuana center or medical marijuana infused product manufacturer if all direct beneficial owners of the licensed businesses are the same. Sent to the Governor.

Marijuana Business Efficiency Measures (SB17‐192): Allows businesses who have tested above the approved levels to retest the product a second time. Requires the MED to adjust the average market rate quarterly and creates another tier to tax retail flower used for extractions at a lower level than flower going right to dispensary shelves. Passed both Houses, sent to the Governor.

Marijuana Pesticides Test Medical Effectiveness (SB17-275): Directs CDPHE to use marijuana taxes to make research grants regarding the medical efficacy of Colorado-grown strains of medical marijuana. Allows licensed marijuana facilities to transfer marijuana to a research facility for purposes of medical research. Killed in the House Business Affairs Committee.

For more information or to schedule an interview, contact Shawna McGregor at or 917-971-7852.

About The Cannabis Business Alliance: The Cannabis Business Alliance (CBA) encourages sensible policies that stimulate economic development and consumer transparency for the medical and retail marijuana industry. CBA promotes best business practices through advising and communicating with its members and other industry representatives, thereby invigorating the communities we serve. CBA also supports education and safety to further protect employees and purchasers within regulated marijuana commerce. For more information, visit Follow us on Facebook and Twitter.

Weed Wire disseminates press releases from companies and organizations in the legal marijuana industry. Email to have your press release added.